California Healthcare Institute (CHI) CEO Provides Testimony on FDA Review Processes and American Innovation

9/27/2011 9:14:54 AM

LA JOLLA, Calif.--(BUSINESS WIRE)--CHI President and Chief Executive Officer David L. Gollaher, Ph.D., today provided testimony before the House Energy and Commerce Health Subcommittee on the regulatory environment for biomedical products and the impact on innovation and job creation.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• California Healthcare Institute (CHI)

• Food and Drug Administration (FDA)

• Biotech/Pharma - Background